Vaccines Europe makes the case for vaccine-specific HTA
Regulatory NewsKari Oakes
Biologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropeRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsKari OakesBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropeRegulatory Intelligence/PolicyResearch, Design and Development